Lawsuit alleges pharma giants funded terror in Iraq
pharmafile | August 2, 2018 | News story | Business Services, Medical Communications, Sales and Marketing | AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism
The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that they gave to the Iraqi government would be used to fund terror attacks against American troops.
The families of dozens of troops who had been injured or killed during the Iraq war have filed a federal lawsuit against AstraZeneca, Johnson & Johnson, Roche, Pfizer and General Electric alleging that the companies had known that the supplies they had given to the Iraqi Health Ministry, in order to win contracts, would be used to fund terror operations.
The British based multinational AstraZeneca confirmed that inquiries had been made as it stated it had “received an inquiry from the U.S. Department of Justice in connection with an anti-corruption investigation relating to activities in Iraq.”
The lawsuit claims that the Iraqi Health Ministry sold the free supplies that were given to them on the black market in order to fund terror attacks against American forces. The health ministry, which at the time was under the control of the radical Shiite cleric Moktada al Sadr, leader of the Mahdi Army, is alleged to have “relied on corruption” in order to fund terror activities.
Sadr’s Mahdi army of 60,000 members has been blamed for thousands of killings. The organisation is accused of leading anti-Sunni death squads that frequently killed civilians during the civil war phase of the Iraq War. The lawsuit claims that the Iraqi Health Ministry employees played prominent roles in the Mahdi army and that the organisation was used to launch attacks, smuggle weapons and gather intelligence. The US government have claimed that Sadr’s army are linked to Iran.
Ryan Sparacino a lawyer acting on behalf of plaintiffs commented that: “As alleged by more than 300 Americans, Iranian-backed terrorists have used corruption at the Iraqi health ministry to help fund their terrorist operations in Iraq since at least 2004.”
However the defendants in the lawsuit have argued that the US government had encouraged them to win contracts with the Iraqi government. They noted in a statement that: “the United States expressly encouraged companies to sell and to donate to the ministry millions of dollars’ worth of medicines and medical supplies.”
Louis Goss
Related Content
Roche’s Alecensa approved by FDA as lung cancer treatment
Roche has announced that the US Food and Drug Administration (FDA) has approved Alecensa (alectinib) …
Genentech’s Columbi meets primary endpoint in phase 3 trial for lymphoma treatment
Genentech, part of the Roche Group, has announced that its phase 3 STARGLO trial has …
AstraZeneca shares results for Imfinzi in phase 3 trial for small cell lung cancer
AstraZeneca has announced positive high-level results from the phase 3 ADRIATIC trial, which demonstrated that …
